| 8765700 |
Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions |
George Tachas, James Karras, Jeffrey R. Crosby, Kenneth Dobie, Frank Bennett |
2014-07-01 |
| 8153603 |
Compositions and their uses directed to IL-4R alpha |
James Karras, Jeffrey R. Crosby, Mausumee Guha, David Tung, Susan M. Freier |
2012-04-10 |
| 7507810 |
Compositions and their uses directed to IL-4R alpha |
James Karras, Susan M. Freier, William Gaarde, Mausumee Guha |
2009-03-24 |
| 7141599 |
Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
Peter Isakson, Gary Anderson |
2006-11-28 |
| 7132441 |
Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
Peter C. Isakson, Gary Anderson |
2006-11-07 |
| 6617345 |
Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
Peter C. Isakson, Gary Anderson |
2003-09-09 |
| 6407140 |
Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
Peter C. Isakson, Gary Anderson |
2002-06-18 |
| 6376528 |
Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
Peter C. Isakson, Gary Anderson |
2002-04-23 |
| 6342510 |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist |
Peter C. Isakson, Gary Anderson |
2002-01-29 |
| 6265439 |
Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives |
Richard A. Mueller, Thomas E. Barta, John McKearn, Richard A. Partis, Francis J. Koszyk |
2001-07-24 |
| 6172096 |
Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
Peter C. Isakson, Gary Anderson |
2001-01-09 |
| 6136839 |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
Peter C. Isakson, Gary Anderson |
2000-10-24 |
| 5990148 |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A.sub.4 hydrolase inhibitor |
Peter C. Isakson, Gary Anderson |
1999-11-23 |
| 5700816 |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A.sub.4 hydrolase inhibitor |
Peter C. Isakson, Gary Anderson |
1997-12-23 |
| 5451604 |
Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives |
Richard A. Mueller, Thomas E. Barta, John McKearn, Richard A. Partis, Francis J. Koszyk |
1995-09-19 |
| 5247119 |
Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives |
Kerry W. Fowler, John Farah, John McKearn, Richard A. Mueller |
1993-09-21 |
| 4785077 |
Substantially pure cytotoxicity triggering factor |
Richard Syd Kornbluth, Thomas S. Edgington |
1988-11-15 |